1-9 of 9
Gaurav Sutrave
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Patterns of Care and Outcomes for Non-Favourable Risk Acute Myeloid Leukemia Treated with Intensive Chemotherapy across Australia and New Zealand- Data Linkage between the ALLG National Blood Cancer Registry (NBCR) and the Australia and New Zealand Transplant and Cellular Therapy (ANZTCT) Registry

Nisha Thiagarajah, Mark R Dowling, Karin Dunne, Donna Aarons, Jenny Collins, Steven Tran, Shaun Fleming, Gaurav Sutrave, Devendra Hiwase, Chun Yew Fong, Blake Hsu, Duncan Purtill, Anne-Marie Watson, Glen A Kennedy, William S Stevenson, Stephen Robert Larsen, John Moore, Travis Perera, David S. Ritchie, Andrew Wei, Andrew W. Roberts, Nada Hamad, Ashish Bajel
Journal: Blood
Blood (2024) 144 (Supplement 1): 3799.
https://doi.org/10.1182/blood-2024-209389
Published: 2024
Journal Articles

Ibrutinib for Steroid Refractory Chronic Graft Vs Host Disease - Real World Experience

Gaurav Sutrave, Tishya Indran, Yatika Jivan, Andrew Hutchison, Nada Hamad, Sui Tan, Duncan Purtill, Andrew Grigg, Siok-Keen Tey, David J. Curtis, David J Gottlieb, Abir Bhattacharyya
Journal: Blood
Blood (2022) 140 (Supplement 1): 10537–10539.
https://doi.org/10.1182/blood-2022-168683
Published: 2022
Journal Articles

Third-Party Partially HLA Matched Fungus-Specific T-Cells (FSTs) Used to Treat Invasive Fungal Infection (IFI) with Scedosporium Aurantiacum after Allogeneic Hemopoietic Stem Cell Transplant (aHSCT)

Shafqat Inam, Gaurav Sutrave, Selmir Avdic, Janine Street, Elissa Atkins, Leighton Edward Clancy, David J Gottlieb
Journal: Blood
Blood (2021) 138 (Supplement 1): 2825.
https://doi.org/10.1182/blood-2021-152384
Published: 2021
Journal Articles

Early Administration of Partially HLA Matched Third Party Virus-Specific T-Cells in Conjunction with Antiviral Treatment for Initial Viral Infection after Allogeneic Stem Cell Transplant Is Safe and Leads to High Rates of Viral Control

Wei Jiang, Gaurav Sutrave, Selmir Avdic, Leighton Edward Clancy, Shafqat Inam, Elissa Atkins, Caroline M Bateman, Adrian Gabriel Selim, Vicki Antonenas, Janine Street, Renee Simms, Peter J. Shaw, David Ritchie, Emily Blyth, David J Gottlieb
Journal: Blood
Blood (2021) 138 (Supplement 1): 255.
https://doi.org/10.1182/blood-2021-152396
Published: 2021
Journal Articles

Investigation of product-derived lymphoma following infusion of piggyBac -modified CD19 chimeric antigen receptor T cells

Clinical Trials & Observations
Kenneth P. Micklethwaite, Kavitha Gowrishankar, Brian S. Gloss, Ziduo Li, Janine A. Street, Leili Moezzi, Melanie A. Mach, Gaurav Sutrave, Leighton E. Clancy, David C. Bishop, Raymond H. Y. Louie, Curtis Cai, Jonathan Foox, Matthew MacKay, Fritz J. Sedlazeck, Piers Blombery, Christopher E. Mason, Fabio Luciani, David J. Gottlieb, Emily Blyth
Journal: Blood
Blood (2021) 138 (16): 1391–1405.
https://doi.org/10.1182/blood.2021010858
Published: 2021
Includes: Supplemental data
Journal Articles

Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac -modified CD19 CAR T cells

Clinical Trials & Observations
David C. Bishop, Leighton E. Clancy, Renee Simms, Jane Burgess, Geetha Mathew, Leili Moezzi, Janine A. Street, Gaurav Sutrave, Elissa Atkins, Helen M. McGuire, Brian S. Gloss, Koon Lee, Wei Jiang, Karen Maddock, Georgia McCaughan, Selmir Avdic, Vicki Antonenas, Tracey A. O’Brien, Peter J. Shaw, David O. Irving, David J. Gottlieb, Emily Blyth, Kenneth P. Micklethwaite
Journal: Blood
Blood (2021) 138 (16): 1504–1509.
https://doi.org/10.1182/blood.2021010813
Published: 2021
Includes: Supplemental data
Journal Articles

Donor-Derived T-Cells Specific for WT1 and PRAME in Combination with T-Cells Specific for Multiple Pathogens for Prevention of Relapse and Infection after Haemopoietic Stem Cell Transplant (HSCT) for Acute Myeloid Leukaemia (AML) or High-Risk Myelodysplasia (MDS) - (The INTACT Trial)

Wei Jiang, MBBS, M Clin MD FRACP, FRCPA, Emily Blyth, B. MDHons), FRACP, FRCPA, PhD, Peter J. Shaw, MA,FRACP, Leighton Edward Clancy, BSc, PhD, Kenneth P. Micklethwaite, MBBS, PhD FRACP, FRCPA, Abir Bhattacharyya, MBBS, FRACP, FRCPA, Elissa Atkins, RN, Selmir Avdic, PhD, Gaurav Sutrave, MBBS, FRACP, FRCPA, Janine Street, BSc MSc (Hons), David Gottlieb, MBBS, MD FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 38.
https://doi.org/10.1182/blood-2020-143136
Published: 2020
Journal Articles

Administration of Third-Party Virus-Specific T-Cells (VST) at the Time of Initial Therapy for Infection after Haemopoietic Stem Cell Transplant Is Safe and Associated with Favourable Clinical Outcomes (the R3ACT-Quickly trial)

David Gottlieb, MBBS, MD FRACP, FRCPA, Wei Jiang, MBBS, BSc, BA, Selmir Avdic, PhD, Leighton Clancy, BSc PhD, Gaurav Sutrave, MBBS, Caroline M Bateman, PhDMBBS,FRACP,FRCPath,MRCP, Elissa Atkins, RN, Adrian Gabriel Selim, MBBS, Vicki Antonenas, BSc, David Collins, RN BSc (HONS) MN MapptMgt, Janine Street, BSc MSc (Hons), Renee Simms, BSc, Peter J. Shaw, MA,FRACP, David Ritchie, MD PhD, Emily Blyth, B. MDHons), FRACP, FRCPA, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 251.
https://doi.org/10.1182/blood-2019-125166
Published: 2019
Journal Articles

3rd Party CMV-Specific T Cells Provide Long Term Protection Against Episodes of Recurrent CMV after Allogeneic Stem Cell Transplant Despite Lack of Persistence in Peripheral Blood

Emily Blyth, Barbara Withers, Leighton Edward Clancy, PhD, Agnes S. M. Yong, MDPhD, Christopher Fraser, MD, Jane Burgess, Renee Simms, Gloria Castellano Gonzalez, PhD, David Kliman, MBBS, Ming-Celine Dubosq, MD, David Bishop, Gaurav Sutrave, MBBS,, Chun Kei Kris Ma, PhDMBBS, Peter J. Shaw, MA,FRACP, Kenneth P. Micklethwaite, MBBS, PhD FRACP, FRCPA, David Gottlieb, MBBS, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 1919.
https://doi.org/10.1182/blood.V130.Suppl_1.1919.1919
Published: 2017